'김갑성' 기자의 전체기사
-
The "Eastern Wisdom" of Aging: How Taikang's "New Life Ins…
SHANGHAI, Dec. 30, 2025 -- Under the global background of ageing people, WallstreetCN reported how TaiKang play its wisdom in new-life-insurance. In 2014, journalists from Japan's NHK documented the phenomenon of A Society Without Bonds, portraying how the elderly in an atomized society—devoid of social, familial, or community ties—gradually become isolated and ultimately pass away alone. A decade later, the Japanese drama Two in the Neighborhood (Douban rating 9.3) offers a starkly different narrative. Its two 55-year-old female protagonists no longer treat aging with tragic s
- 김갑성 기자
- 2025-12-30 19:34
-
Insilico Medicine Lists on Hong Kong Stock Exchange, Sho…
HONG KONG, Dec. 30, 2025 -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, becoming the first AI-driven biotech company to go public in Main Board under Chapter 8.05 listing rules of the HKEX. This initial public offering (IPO) raised a total of HKD 2.277 billion, achieving the largest biotech IPO in Hong Kong this year, as in the size of fundraising. "With this massively oversubscribed listing we set several world's firsts
- 김갑성 기자
- 2025-12-30 17:00
-
Masa Draws the Sea Again
The Norwegian Refugee Council's Better Learning Programme, funded by Education Cannot Wait, delivers mental health and psychosocial support alongside education for children in Gaza. GAZA, Palestine, Dec. 30, 2025 -- In a tent in Deir al-Balah, Gaza, 12-year-old Masa carefully places her colored pencil on the page, tracing the curve of a wave. Her brown hair is pulled back in a ponytail, secured with two plastic barrettes. The sea she draws is calm and glimmering. In her real world, nothing is calm. But in this small act of creativity – in the rhythm of drawing a
- 김갑성 기자
- 2025-12-30 13:50
-
Dr. Lu Xianping, Founder, Chairman of Chipscreen Bioscien…
SHENZHEN, China, Dec. 30, 2025 -- On December 5, 2025, Dr. Lu Xianping, Founder, Chairman of Shenzhen Chipscreen Biosciences Co., Ltd, has been named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards. This recognition honors his outstanding contributions to advancing new-quality productive forces and driving innovation within the pharmaceutical industry. The award program, themed "Two Decades of Unwavering Strength, Forging Ahead in the New Era," celebrates entrepreneurs who shoulder new-era responsibilities and contribute significantl
- 김갑성 기자
- 2025-12-30 08:45
-
Bioelectric Toothbrush Offers New Approach with 6x Plaque R…
[ 메디채널 김갑성 기자 ] Clinically validated microcurrent technology now available in the U.S. market SAN FRANCISCO, Dec. 29, 2025 -- Great Gums Inc. today announced the U.S. launch of its bioelectric toothbrush, a clinically validated oral care device that delivers safe microcurrents to remove plaque from hard-to-reach areas where traditional bristles cannot effectively clean. According to clinical studies, the bioelectric method demonstrated a sixfold improvement in plaque removal efficiency in deep, difficult-to-access regions of the mouth compared to traditional brushing.[
- 김갑성 기자
- 2025-12-29 21:00
-
HKSH Medical Group and Southern University of Science and…
HONG KONG, Dec. 29, 2025 -- HKSH Medical Group ("HKSH") and Southern University of Science and Technology ("SUSTech") officially signed a Memorandum of Understanding ("MOU") on 15 December 2025, a significant initiative to deepen collaboration between Hong Kong and the Chinese Mainland in the fields of medicine and medical physics. During the signing ceremony, Dr. Walton LI, Chief Executive Officer of HKSH Medical Group and Medical Superintendent of Hong Kong Sanatorium & Hospital, and Professor JIANG Hong, Party Secretary of SU
- 김갑성 기자
- 2025-12-29 16:12
-
Adventures in DMPK: Viva Biotech's One-Stop Pharmacology…
SHANGHAI, Dec. 29, 2025 -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has responded by building an integrated pharmacology platform that covers this end-to-end modality range, supporting programs from in vitro ADME assays through in vivo PK and efficacy studies. Adventures in DMPK: From Small Molecules and PROTACs to Peptides and Antibodies, the latest session in the Viva BioInsights webinar series, was presented by Dr. Justin Cu
- 김갑성 기자
- 2025-12-29 14:13
-
Alphamab Oncology Announces IND Application for a Phase…
SUZHOU, China, Dec. 29, 2025 -- Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 bispecific antibody-drug conjugate (ADC) and PD-L1 immune checkpoint inhibitor) in combination with platinum-based chemotherapy with or without bevacizumab as first-line treatment of advanced cervical cancer (Study Number: JSKN033-202), has been officially accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). C
- 김갑성 기자
- 2025-12-29 13:52
-
Senhwa Biosciences Aims at Multi-Billion Dollar Global Market w…
TAIPEI and SAN DIEGO, Dec. 29, 2025 -- Following its recent clinical collaboration with the multinational pharmaceutical company BeOne Medicines to explore combination therapy with its marketed PD-1 inhibitor in the challenging field of cold tumor treatment, Senhwa Biosciences, Inc. (TPEx: 6492, hereafter "Senhwa"), today announced another major milestone. The Company's first-in-class investigational drug Pidnarulex (CX-5461) will be evaluated in combination with the globally recognized antibody-drug conjugate (ADC), Trastuzumab Deruxtecan (Enhertu®), in a Phase 1b clini
- 김갑성 기자
- 2025-12-29 10:24
-
Assure Healthcare Holdings Opens Second Clinic in Woodl…
SINGAPORE, Dec. 29, 2025 -- Assure Healthcare Holdings, a subsidiary of SingWealth Holdings, today announced the official opening of its second clinic, Assure Family Clinic Woodlands. This expansion marks the next phase in the Group's mission to make quality and comprehensive healthcare more accessible to families and individuals. Located in the heart of Woodlands at 132 Marsiling Rise, the new clinic extends Assure Healthcare Holdings' footprint beyond its first location in Bukit Merah. The clinic will provide residents in northern Singapore with convenient access to g
- 김갑성 기자
- 2025-12-29 10:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 16:15
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
- SKF completes previously announced divestment of non-core aerospace operation in Elgin, USA 03:36
- DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion 03:34
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 01월 31일 17시 40분